Log in to save to my catalogue

Issues with Intravitreal Administration of Anti-VEGF Drugs

Issues with Intravitreal Administration of Anti-VEGF Drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee8212c44d6c45a1a1c529de79cc6ef3

Issues with Intravitreal Administration of Anti-VEGF Drugs

About this item

Full title

Issues with Intravitreal Administration of Anti-VEGF Drugs

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.897-904

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

To provide an update of summary of risk factors and side effects of long-term use and contamination of intravitreal anti-VEGF injections.
We reviewed relevant publications of the topic of contamination of anti-VEGF injections and long-term side effects due to this reason.
Due to the long-term use of anti-VEGF drugs and the higher number of in...

Alternative Titles

Full title

Issues with Intravitreal Administration of Anti-VEGF Drugs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ee8212c44d6c45a1a1c529de79cc6ef3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee8212c44d6c45a1a1c529de79cc6ef3

Other Identifiers

ISSN

1177-5483,1177-5467

E-ISSN

1177-5483

DOI

10.2147/OPTH.S207978

How to access this item